Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum - Clinical Case Scenarios for Specialists

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine.

Apply your knowledge and practice skills by examining two prostate cancer patients. Each clinical case scenario allows you to work through treatment and management. Learners will explore systemic and directed therapy and the role of radiation, chemotherapy and/or hormone therapy.

  Release Date: November 23, 2022
  Expiration Date: November 22, 2025
  Estimated Time to Complete: ~30 minutes
  Registration Fee: FREE 

Learn more about the Prostate Cancer CME Series HERE.

1. Identify the appropriate imaging techniques to be utilized in biochemically recurrent prostate cancer.
2. Recommend when the treatment plan should include radiation, chemotherapy and/or hormone therapy.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require accommodations, please contact the Stanford CME.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

References

Riga, A, Anstis, S, Thornton, IM, et al. (n.d.). Following Randolph Blake's furrow further.. Journal of vision. https://pubmed.ncbi.nlm.nih.gov/40408119

Kohrt, BA, Ojagbemi, A, Luitel, NP, et al. (n.d.). An App-Based WHO Mental Health Guide for Depression Detection: A Cluster Randomized Clinical Trial.. JAMA network open. https://pubmed.ncbi.nlm.nih.gov/40408108

Click here to view the list of references.

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the table below. All of the relevant financial relationships listed for these individuals have been mitigated.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Ali R Raza Khaki, MD
Clinical Assistant Professor
Stanford Health Care (SHC)

Course Director, Faculty

Stocks or stock options, excluding diversified mutual funds-Doximity (Relationship has ended)

Sumit Anil Shah, MD
Clinical Associate Professor
Stanford Health Care

Course Director, Faculty

Advisor-Natera|Grant or research support-Genentech, Inc.

Hilary Petersmeyer Bagshaw, MD
Stanford University

Faculty

Nothing to disclose

Ruth Adewuya, MD
Managing Director
Stanford University School of Medicine

Planner, Reviewer

Nothing to disclose

This CME activity is supported by an educational grant from Astellas Pharma Global Development, Inc. and its collaborative partner, Pfizer, Inc.